CD40-activated B cells contribute to mesothelioma tumor regression
| Main Authors: | Jackaman, Connie, Cornwall, Scott, Graham, Peter, Nelson, Delia |
|---|---|
| Format: | Journal Article |
| Published: |
Nature Publishing Group
2011
|
| Online Access: | http://www.nature.com/icb/journal/v89/n2/full/icb201088a.html http://hdl.handle.net/20.500.11937/49430 |
Similar Items
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014)
by: Jackaman, Connie, et al.
Published: (2014)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
by: Gardner, J., et al.
Published: (2015)
by: Gardner, J., et al.
Published: (2015)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Rapid copper acquisition by developing murine mesothelioma: Decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration
by: Crowe, Andrew, et al.
Published: (2013)
by: Crowe, Andrew, et al.
Published: (2013)
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
Murine mesothelioma induces locally-proliferating IL-10+TNF-a+CD206-CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy
by: Jackaman, Connie, et al.
Published: (2016)
by: Jackaman, Connie, et al.
Published: (2016)
Studies on the Effect of Aging and Mesothelioma on Dendritic Cell Subsets
by: Cornwall, Scott M.J.
Published: (2015)
by: Cornwall, Scott M.J.
Published: (2015)
Lipid-laden partially-activated plasmacytoid and CD4-CD8a+ dendritic cells accumulate in tissues in elderly mice
by: Gardner, Joanne, et al.
Published: (2014)
by: Gardner, Joanne, et al.
Published: (2014)
Human mesothelioma induces defects in dendritic cell numbers and antigen processing function which predict survival outcomes
by: Cornwall, S., et al.
Published: (2015)
by: Cornwall, S., et al.
Published: (2015)
Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
by: Jackaman, Connie, et al.
Published: (2013)
by: Jackaman, Connie, et al.
Published: (2013)
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia
by: Duong, L., et al.
Published: (2018)
by: Duong, L., et al.
Published: (2018)
CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy
by: Jackaman, Connie, et al.
Published: (2019)
by: Jackaman, Connie, et al.
Published: (2019)
Targeting macrophages rescues age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2016)
by: Jackaman, Connie, et al.
Published: (2016)
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
by: Gardner, J., et al.
Published: (2017)
by: Gardner, J., et al.
Published: (2017)
The use of agonistic anti-CD40 therapy in treatments for cancer
by: Khong, A., et al.
Published: (2012)
by: Khong, A., et al.
Published: (2012)
The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Nelson, Delia, et al.
Published: (2014)
by: Nelson, Delia, et al.
Published: (2014)
Turning the tumor microenvironment into a self vaccine site
by: Nelson, Delia
Published: (2012)
by: Nelson, Delia
Published: (2012)
Combining chemotherapy with immunotherapy to treat mesothelioma: an investigation into the role of CD4+ T cells in a murine model
by: Steer, Henry John
Published: (2013)
by: Steer, Henry John
Published: (2013)
MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)
by: Sim, M., et al.
Published: (2016)
Sarcostemma viminale activates macrophages to a pro-inflammatory phenotype
by: Brestovac, Brian, et al.
Published: (2014)
by: Brestovac, Brian, et al.
Published: (2014)
Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T- and B-cell zones
by: Tomay, F., et al.
Published: (2018)
by: Tomay, F., et al.
Published: (2018)
Mesothelioma risk After 40 Years Since First Exposure to Asbestos: a Pooled Analysis
by: Reid, Alison, et al.
Published: (2014)
by: Reid, Alison, et al.
Published: (2014)
Citrullinated vimentin presented on MHC-II in tumor cells is a target for CD4+ T-cell-mediated antitumor immunity
by: Brentville, Victoria A., et al.
Published: (2016)
by: Brentville, Victoria A., et al.
Published: (2016)
Aging induces increased expression of checkpoint inhibitory molecules on dendritic cells
by: Gardner, J., et al.
Published: (2016)
by: Gardner, J., et al.
Published: (2016)
Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)
by: Brims, Fraser
Published: (2018)
Henoch-Schonlein purpura in mesothelioma
by: Joshi, S., et al.
Published: (2014)
by: Joshi, S., et al.
Published: (2014)
Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)
by: Richards, Alexander S.K.
Published: (2016)
Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)
by: Musk, A., et al.
Published: (2017)
Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)
by: Musk, A., et al.
Published: (2011)
Ageing and Mesothelioma Drive Lipid Accumulation and Dysfunction in Dendritic Cells and Macrophages
by: Sheeraz, Mohd
Published: (2022)
by: Sheeraz, Mohd
Published: (2022)
Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)
by: Fox, Simon, et al.
Published: (2013)
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
by: Ismail, Ruzila, et al.
Published: (2016)
by: Ismail, Ruzila, et al.
Published: (2016)
Persediaan ekonomi M40 ke B40
by: Nadzi, Nur Izzati Izzah
Published: (2021)
by: Nadzi, Nur Izzati Izzah
Published: (2021)
Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
by: Jackaman, Connie, et al.
Published: (2013)
by: Jackaman, Connie, et al.
Published: (2013)
Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)
by: Kusmiaty
Published: (2003)
Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)
by: De Klerk, N., et al.
Published: (2016)
Similar Items
-
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014) -
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012) -
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
by: Jackaman, Connie, et al.
Published: (2012) -
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
by: Gardner, J., et al.
Published: (2015) -
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)